AnPac Bio-Medical Science Acquires GISN LIMITED, a Technical Solution and Outsourcing Consulting Services Provider
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
About 62% of Anpac Bio's investor base is looking to short. The analysis of current outlook of investing in Anpac Bio Medical suggests that many traders are alarmed regarding Anpac Bio's prospects. The current market sentiment, together with Anpac Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Anpac Bio Medical stock news signals to limit their universe of possible portfolio assets.
Anpac |
AnPac Bio-Medical Science Co., Ltd. , a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian sourced food products, announced the closing of the acquisition of GISN LIMITED , a technical solution and outsourcing consulting services provider focused on the digital, internet and Web 3 busin
Read at finance.yahoo.com
 |
Anpac Bio Fundamental Analysis
We analyze Anpac Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anpac Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anpac Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Anpac Bio is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Anpac Bio Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anpac Bio stock to make a market-neutral strategy. Peer analysis of Anpac Bio could also be used in its relative valuation, which is a method of valuing Anpac Bio by comparing valuation metrics with similar companies.
Peers
Anpac Bio Related Equities
| ANTX | AN2 Therapeutics | 21.90 | ||||
| OPT | Opthea | 10.81 | ||||
| MRKR | Marker Therapeutics | 9.72 | ||||
| CCCC | C4 Therapeutics | 8.59 | ||||
| ALRN | Aileron Therapeutics | 4.38 | ||||
| ABVC | ABVC Biopharma | 3.92 | ||||
| EWTX | Edgewise Therapeutics | 2.48 | ||||
| HOWL | Werewolf Therapeutics | 1.52 | ||||
| PMVP | Pmv Pharmaceuticals | 1.25 | ||||
| ACRV | Acrivon Therapeutics, | 0.80 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| AVTE | Aerovate Therapeutics | 0.38 | ||||
| CELC | Celcuity LLC | 0.39 | ||||
| LUMO | Lumos Pharma | 0.46 | ||||
| PTIX | Protagenic Therapeutics | 1.67 | ||||
| XCUR | Exicure | 7.81 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets |